Loading...

INBX INHIBRX BIOSCIENCES INC Management Changes 8-K Filing

NHBR

NBX

INHIBRX BIOSCIENCES INC

(INBX)

2025 8-K

Financial Results Announced

Clinical Trial Update

Clinical Data Update

Financial Results Announcement

Corporate Presentation Update

Clinical Trial Update

Financial Results Announced

Positive Trial Results

Financial Results Announcement

Financial Statements

Management Changes

Financial Results

Ozekibart Data Release

Financial Results

External Links:

On May 28, 2025, Inhibrx Biosciences held its Annual Meeting where 79% of eligible shares were represented, electing two directors and ratifying BDO USA as the independent accounting firm for 2025.

AI Assistant

INHIBRX BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.